Cargando…
PARPs in genome stability and signal transduction: implications for cancer therapy
The poly(ADP-ribose) polymerase (PARP) superfamily of enzymes catalyses the ADP-ribosylation (ADPr) of target proteins by using nicotinamide adenine dinucleotide (NAD(+)) as a donor. ADPr reactions occur either in the form of attachment of a single ADP-ribose nucleotide unit on target proteins or in...
Autores principales: | Palazzo, Luca, Ahel, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299239/ https://www.ncbi.nlm.nih.gov/pubmed/30420415 http://dx.doi.org/10.1042/BST20180418 |
Ejemplares similares
-
ADP-ribosylation signalling and human disease
por: Palazzo, Luca, et al.
Publicado: (2019) -
Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023) -
Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Prokhorova, Evgeniia, et al.
Publicado: (2021) -
HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
por: Gibbs-Seymour, Ian, et al.
Publicado: (2016) -
Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
por: Bilokapic, Silvija, et al.
Publicado: (2020)